Document
IPR2016-01131, No. 2078-187 Exhibit - Medical Officers Review of NDA 21 023 (P.T.A.B. Jul. 14, 2017)
Cite Document
IPR2016-01131, No. 2078-187 Exhibit - Medical Officers Review of NDA 21 023 (P.T.A.B. Jul. 14, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2025-43 Exhibit - Declaration of Dr Thorsteinn Loftsson, PhD (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2025-43 Exhibit - Declaration of Dr Thorsteinn Loftsson, PhD (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2047-59 Exhibit - Allergan Inc Credit Suisse First Boston Equity Research Report, Jan 30, 2003 (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2047-59 Exhibit - Allergan Inc Credit Suisse First Boston Equity Research Report, Jan 30, 2003 (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2002-7 Exhibit - US Pat No 4,839,342 (P.T.A.B. Sep. 9, 2016)
Cite Document
IPR2016-01131, No. 2002-7 Exhibit - US Pat No 4,839,342 (P.T.A.B. Sep. 9, 2016)
+ More Snippets
Document
IPR2016-01131, No. 1171-269 Exhibit - EX1171 HR098P1PS Excerpts (P.T.A.B. Mar. 14, 2018)
Cite Document
IPR2016-01131, No. 1171-269 Exhibit - EX1171 HR098P1PS Excerpts (P.T.A.B. Mar. 14, 2018)
+ More Snippets
Document
IPR2016-01131, No. 1087-134 Exhibit - Exhibit 1087 Schachet the golden age of dry eye (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1087-134 Exhibit - Exhibit 1087 Schachet the golden age of dry eye (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1039-178 Exhibit - PROTECTIVE ORDER MATERIAL Exhibit 1039 Declaration of Andrew Calman (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1039-178 Exhibit - PROTECTIVE ORDER MATERIAL Exhibit 1039 Declaration of Andrew Calman (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1068-115 Exhibit - Exhibit 1068 Allergan Inc 1993 10 K (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1068-115 Exhibit - Exhibit 1068 Allergan Inc 1993 10 K (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2042-57 Exhibit - Jonathan R Pirnazar, MD Taking a Custom Approach to Dry Eye Treatment (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2042-57 Exhibit - Jonathan R Pirnazar, MD Taking a Custom Approach to Dry Eye Treatment (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2082-191 Exhibit - Deposition transcript of Andrew F Calman, MD, PhD (P.T.A.B. Jul. 20, 2017)
Cite Document
IPR2016-01131, No. 2082-191 Exhibit - Deposition transcript of Andrew F Calman, MD, PhD (P.T.A.B. Jul. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1133-185 Exhibit - Exhibit 1133 Declaration of Anna G Phillips ISO Petitioner Mylan Pharmaceuticals Incs Motion for Pro Hac Vice Admission (P.T.A.B. Jul. 7, 2017)
Cite Document
IPR2016-01131, No. 1133-185 Exhibit - Exhibit 1133 Declaration of Anna G Phillips ISO Petitioner Mylan Pharmaceuticals Incs Motion for Pro Hac Vice Admission (P.T.A.B. Jul. 7, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1062-109 Exhibit - Exhibit 1062 Akpek et al (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1062-109 Exhibit - Exhibit 1062 Akpek et al (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 1080-127 Exhibit - Exhibit 1080 Scleral Lenses (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01131, No. 1080-127 Exhibit - Exhibit 1080 Scleral Lenses (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01131, No. 2068-67 Exhibit - Iazuka and Jin The Effect of Prescription Drug Advertising on Doctor Visits (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01131, No. 2068-67 Exhibit - Iazuka and Jin The Effect of Prescription Drug Advertising on Doctor Visits (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01131, No. 3003-270 Exhibit - United States Court of Appealsfor the Federal Circuit SAINT REGIS MOHAWK TRIBE, ALLERGAN, INC,Appellants,vMYLAN PHARMACEUTICA...
Cite Document
IPR2016-01131, No. 3003-270 Exhibit - United States Court of Appealsfor the Federal Circuit SAINT REGIS MOHAWK TRIBE, ALLERGAN, INC,Appellants,vMYLAN PHARMACEUTICALS INC, TEVAPHAR
+ More Snippets